Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eaton Corporation plc (ETN) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance

Eaton Corporation plcTrade
Nuvation Bio Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Eaton Corporation plc vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Eaton Corporation plc trades at $428.91 (market cap $167.53B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: Eaton Corporation plc is far larger — about 98× Nuvation Bio Inc. Class A Common Stock's market cap, and Eaton Corporation plc pays a 1.02% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 31 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.

ETNNUVB
Market Cap
$167.53B$1.71B
Volume
1,729,1945,448,712
Sector
IndustrialsHealth
52-Week High
$459.96$9.54
52-Week Low
$315.82$3.41
Typical Hold Time
31 Days0 Days
Enterprise Value
$188.16B$1.30B
Dividend Yield
1.02%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eaton Corporation plc

Eaton Corporation (ETN) trades at $431.33, down 3.09% today but maintains strong analyst support with 28 buy ratings and a $502.38 consensus price target. The company demonstrates consistent earnings beats in recent quarters and benefits from strategic acquisitions in data center and aerospace markets. Technical indicators show a bullish moving average trend with neutral oscillators, while fundamentals reveal solid profitability with 12.75% net income margin and 19.71% ROE.

ETN presents a compelling investment case driven by AI data center demand and grid modernization trends, though elevated valuation multiples (P/E 43.92) warrant monitoring. Key risks include execution of recent acquisitions and competitive pressures in the electrical equipment sector. The stock offers 16% upside to consensus targets with strong institutional conviction supporting long-term growth prospects.

Nuvation Bio Inc. Class A Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ETN
73% Buy27% Sell
Avg holding period · 31 Days
NUVB
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Eaton Corporation plc

Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.

Read more on ETN →

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.

Read more on NUVB →